National Cancer Institute; Notice of Closed Meeting, 33750 [2012-13837]
Download as PDF
<![CDATA[
33750
Federal Register / Vol. 77, No. 110 / Thursday, June 7, 2012 / Notices
Grant No.
Grantee name
Grantee city
U17RH23237 .................
SouthEast Alaska Regional Health Consortium ....
Sitka .............
Intended Recipient of the Award:
SouthEast Alaska Regional Health
Consortium.
Amount of the Award: $700,000.00.
Project Period: September 1, 2011
through March 31, 2013.
Authority: Section 330A of the Public
Health Service Act, as amended, (42 U.S.C.
254c).
Justification
The Medicare Prescription Drug
Improvement and Modernization Act of
2003 (MMA) authorized CMS to
conduct a demonstration program in
which FESCs would be treated as
Medicare providers. The CMS
demonstration took several years to
develop and officially began on April 1,
2010, when the first clinic site
submitted the first claim to CMS. This
3-year demonstration will run until
March 2013.
In 2004, Congress appropriated funds
to HRSA to undertake a demonstration
project that supports the development of
a FESC CMS Medicare provider type. By
supplementing the award to the current
recipient, there will be continued
support to keep the FESC sites
participating through (or close to) the
end of the CMS demonstration. The
CMS demonstration provides payments
only for FESC services provided to
Medicare beneficiaries. On average, only
20 percent of FESC services are
Medicare-eligible, meaning that the
clinics do not receive payment for as
much as 80 percent of their FESC
services. HRSA funds provide support
for those services that are not
reimbursed by Medicare.
srobinson on DSK4SPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Aaron Fischbach, Health Resources and
Services Administration, Office of Rural
Health Policy, 5600 Fishers Lane, Room
5A–05, Rockville, Maryland 20852, or
email afischbach@hrsa.gov.
Dated: May 30, 2012.
Mary K. Wakefield,
Administrator, Health Resources and Services
Administration.
BILLING CODE 4165–15–P
VerDate Mar<15>2010
17:48 Jun 06, 2012
Jkt 226001
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
CFDA Number: 93.912.
[FR Doc. 2012–13831 Filed 6–6–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Review of
a K22 Application.
Date: June 12, 2012.
Time: 5:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Sergei Radaev, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 8113, Bethesda, MD 20892, 301–435–
5655, sradaev@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Grantee state
CFDA No.
AK
Recommended
supplemental
award amount
93.912
$700,000.00
Dated: June 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–13837 Filed 6–6–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel Interdisciplinary
Training and Education for Type 1 Diabetes
Research (T90/R90).
Date: June 26, 2012.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Lakshmanan Sankaran,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 755, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, ls38z@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 77, Number 110 (Thursday, June 7, 2012)]
[Notices]
[Page 33750]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-13837]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Review of a K22 Application.
Date: June 12, 2012.
Time: 5:30 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Radaev, Ph.D., Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8113, Bethesda, MD 20892, 301-435-5655,
sradaev@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 1, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-13837 Filed 6-6-12; 8:45 am]
BILLING CODE 4140-01-P
